Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor PD-L1 selectively suppresses type I interferon in myeloid cells to suppress CTL recruitment to promote lung metastasis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.18.449028Source: DataRank Database

Tumor PD-L1 selectively suppresses type I interferon in myeloid cells to suppress CTL recruitment to promote lung metastasis is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (22)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Priscilla S. Redd,Chunwan Lu ORCID,Alyssa D. Merting ORCID,Dakota B. Poschel,Dafeng Yang ORCID

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W3174970822

National Institutes of Health

Grant: 5F30CA236436-04

Function of IRF8 in T cell activation and immune tolerance

National Institutes of Health

Grant: 5R01CA227433-05

TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE

National Institutes of Health

Grant: 5I01CX001364-02

Type I Interferon Regulation of PD-L1 Expression and Function in MDSCs

National Institutes of Health

Grant: 5R01CA133085-08

Role of IRF8 in Tumor Rejection and Suppression

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/06/18/2021.06.18.449028.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.06.18.449028

repositoryhttps://doi.org/10.1101/2021.06.18.449028

https://dx.doi.org/10.1101/2021.06.18.449028

Fields of Study

Cancer Immunotherapy and BiomarkersImmune cells in cancerImmune Cell Function and Interaction0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

CTL*Cancer researchCytotoxic T cellMetastasisImmunotherapyImmune systemBiologyInterferonCXCL9ChemokineCytokineT cellImmunologyCXCL10CD8Cancer

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being